{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:03:53Z","timestamp":1789578233414,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>We identified novel clinical and dosimetric prognostic factors affecting breast cancer-related lymphedema after postoperative radiotherapy (RT) and developed a multivariable logistic regression model to predict lymphedema in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and materials<\/jats:title><jats:p>In total, 580 patients with unilateral breast cancer were retrospectively reviewed. All patients underwent breast surgery and postoperative RT with or without systemic treatment in 2015. Among the 580 patients, 532 with available RT plan data were randomly divided into training (n=372) and test (n=160) cohorts at a 7:3 ratio to generate and validate the lymphedema prediction models, respectively. An area under the curve (AUC) value was estimated to compare models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median follow-up duration was 5.4 years. In total, 104 (17.9%) patients experienced lymphedema with a cumulative incidence as follows: 1 year, 10.5%; 3 years, 16.4%; and 5 years, 17.6%. Multivariate analysis showed that body mass index \u226525 kg\/m<jats:sup>2<\/jats:sup> (hazard ratio [HR] 1.845), dissected lymph nodes \u22657 (HR 1.789), and taxane-base chemotherapy (HR 4.200) were significantly associated with increased lymphedema risk. Conversely, receipt of RT at least 1 month after surgery reduced the risk of lymphedema (HR 0.638). A multivariable logistic regression model using the above factors, as well as the minimum dose of axillary level I and supraclavicular lymph node, was created with an AUC of 0.761 and 0.794 in the training and test cohorts, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study demonstrated that a shorter interval from surgery to RT and other established clinical factors were associated with increased lymphedema risk. By combining these factors with two dosimetric parameters, we propose a multivariable logistic regression model for breast cancer-related lymphedema prediction after RT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.1026043","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T08:19:59Z","timestamp":1666772399000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jae Sik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4089-0","article-title":"Radiation therapy targets and the risk of breast cancer-related lymphedema: A systematic review and network meta-analysis","volume":"162","author":"Shaitelman","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4899","article-title":"Lymphedema after breast cancer: Incidence, risk factors, and effect on upper body function","volume":"26","author":"Hayes","year":"2008","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pon.1573","article-title":"Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment","volume":"19","author":"Chachaj","year":"2010","journal-title":"Psychooncology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","article-title":"Timing of lymphedema after treatment for breast cancer: When are patients most At risk","volume":"103","author":"McDuff","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2019.04.001","article-title":"Fibrosis and secondary lymphedema: Chicken or egg","volume":"209","author":"Kataru","year":"2019","journal-title":"Transl Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4451-x","article-title":"Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema","volume":"166","author":"Kaufman","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnss.2019.12.007","article-title":"A scoring system for predicting the risk of breast cancer-related lymphedema","volume":"7","author":"Li","year":"2020","journal-title":"Int J Nurs Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003491","article-title":"Risk of lymphedema following contemporary treatment for breast cancer","volume":"274","author":"Byun","year":"2021","journal-title":"Ann Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.24373","article-title":"Development and validation of a risk model for breast cancer\u2013related lymphedema","volume":"3","author":"Kwan","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2021.102023","article-title":"Developing and validating a prediction model for lymphedema detection in breast cancer survivors","volume":"54","author":"Wei","year":"2021","journal-title":"Eur J Oncol Nurs"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06507-x","article-title":"Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: A large multi-institutional study (KROG 20-05)","volume":"192","author":"Byun","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.079","article-title":"Breast cancer\u2013related lymphedema after neoadjuvant chemotherapy","volume":"47","author":"Kim","year":"2014","journal-title":"Cancer Res Treat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2015.463","article-title":"Identification of prognostic risk factors for transient and persistent lymphedema after multimodal treatment for breast cancer","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: Combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.03.046","article-title":"Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer","volume":"102","author":"Gross","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.06.2509","article-title":"Determining the organ at risk for lymphedema after regional nodal irradiation in breast cancer","volume":"105","author":"Gross","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.07.1691","article-title":"Predictors of pneumonitis after conventionally fractionated radiotherapy for locally advanced lung cancer","volume":"111","author":"McFarlane","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3137-x","article-title":"Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients","volume":"148","author":"Jung","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2005.3.208","article-title":"A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population","volume":"3","author":"Armer","year":"2005","journal-title":"Lymphat Res Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5606\/tftrd.2018.3539","article-title":"Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists","volume":"64","author":"Borman","year":"2018","journal-title":"Turkish J Phys Med Rehabil"},{"key":"B22","unstructured":"Supplemental screening for breast cancer in women with dense breasts: A systematic review for the U.S. preventive service task force\n            MelnikowJ\n            FentonJJ\n            WhitlockEP\n            MigliorettiDL\n            WeyrichMS\n            ThompsonJH"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13014-021-01771-z","article-title":"Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery","volume":"16","author":"Chung","year":"2021","journal-title":"Radiat Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13014-021-01923-1","article-title":"Evaluation of deep learning-based autosegmentation in breast cancer radiotherapy","volume":"16","author":"Byun","year":"2021","journal-title":"Radiat Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2154","article-title":"Conditional survival: A useful concept to provide information on how prognosis evolves over time","volume":"21","author":"Hieke","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000001864","article-title":"Lymphedema incidence after axillary lymph node dissection","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1524-4741.2009.00855.x","article-title":"Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients","volume":"16","author":"Helyer","year":"2010","journal-title":"Breast J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment","volume":"16","author":"Semb","year":"1998","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2006.11.003","article-title":"Lymphedema following axillary lymph node dissection for breast cancer","volume":"15","author":"Sakorafas","year":"2006","journal-title":"Surg Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.02.080","article-title":"Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation","volume":"72","author":"Hayes","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(02)04273-6","article-title":"Risk of lymphedema after regional nodal irradiation with breast conservation therapy","volume":"55","author":"Coen","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: A prospective cohort study","volume":"88","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1026043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T08:20:03Z","timestamp":1666772403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1026043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":33,"alternative-id":["10.3389\/fonc.2022.1026043"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1026043","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"article-number":"1026043"}}